If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHammerson Regulatory News (HMSO)

Share Price Information for Hammerson (HMSO)

Share Price is delayed by 15 minutes
Get Live Data
373.60    1.80 (0.48%)
Bid:
373.20
Ask:
373.80
Spread: 0.60 (0.161%)
Market Cap: £1.98b
HMSO Live PriceLast checked at - London Stock Exchange

Intraday Hammerson Share Chart

Final Dividend and Enhanced Scrip Alternative

5 May 2022 07:00

RNS Number : 3330K
Hammerson PLC
05 May 2022
 

THIS ANNOUNCEMENT (AND THE INFORMATION CONTAINED HEREIN) IS NOT FOR RELEASE, PUBLICATION, DISTRIBUTION OR FORWARDING, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION.

FOR IMMEDIATE RELEASE

Hammerson plc (the "Company")

Final 2021 Dividend and Enhanced Scrip Dividend Alternative

5 May 2022

 

Further to the announcement of the Final 2021 Dividend and the Enhanced Scrip Dividend Alternative on Friday, 4 March 2022, the Board of Hammerson plc announces that valid elections to participate in the Enhanced Scrip Dividend Alternative were received from Shareholders holding 3,716,406,719 Shares. Accordingly, the number of New Shares to be issued under the Enhanced Scrip Dividend Alternative is 194,637,920.

 

Therefore, applications have been submitted for 194,637,920 New Shares to be admitted to trading on the London Stock Exchange, the secondary listing segment of the Official List of the Irish Stock Exchange plc, trading as Euronext Dublin, and the Johannesburg Stock Exchange, which will bring the total number of issued 5 pence ordinary shares in the Company to 4,614,095,081.

 

The New Shares are expected to be issued and admitted to trading on the Main Market of the London Stock Exchange, Euronext Dublin and the Johannesburg Stock Exchange on Tuesday, 10 May 2022. A further announcement will be released to confirm when those New Shares have been issued and admitted to trading on the respective stock exchanges.

 

Unless otherwise stated, capitalised terms in this announcement shall have the meanings given to them in the Circular dated Wednesday, 23 March 2022 in connection with the Final 2021 Dividend and Enhanced Scrip Dividend Alternative which can be found at: https://www.hammerson.com/investors/dividend/scrip-dividend 

 

Enquiries

 

Josh Warren, Director of Strategy and Investor Relations

Tel: +44 20 7887 1053

josh.warren@hammerson.com

 

The announcement above has also been released on the SENS system of the Johannesburg Stock Exchange and on Euronext Dublin.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVUPURUAUPPGWC
Date   Source Headline
19th Sep 20253:30 pmRNSDirector/PDMR Shareholding
11th Sep 20254:45 pmRNSHolding(s) in Company
9th Sep 20257:00 amRNSAppointment of Rob Wilkinson as CEO
4th Sep 20253:30 pmRNSPublication of Supplementary EMTN Prospectus
29th Aug 202512:30 pmRNSTotal Voting Rights
28th Aug 20259:30 amRNSHolding(s) in Company
27th Aug 20259:00 amRNSDividend Currency Conversion Announcement
19th Aug 20253:00 pmRNSHolding(s) in Company
15th Aug 20258:15 amRNSTotal Voting Rights
12th Aug 202510:00 amRNSAnnouncement of Applications for Second Admission
8th Aug 20253:15 pmRNSAnnouncement of SARB Approval
8th Aug 20257:00 amRNSAcquisition
7th Aug 20258:00 amRNSHolding(s) in Company
5th Aug 20253:00 pmRNSTotal Voting Rights
5th Aug 20258:15 amRNSTotal Voting Rights
1st Aug 20253:00 pmRNSTotal Voting Rights
31st Jul 20254:40 pmRNSRESULTS OF PLACING
31st Jul 20257:30 amRNSTransaction in Own Shares
31st Jul 20257:02 amRNSDividend Declaration
31st Jul 20257:01 amRNSPROPOSED PLACING TO FUND ACQUISITION
31st Jul 20257:00 amRNSHalf-year Report
30th Jul 20257:00 amRNSTransaction in Own Shares
29th Jul 20254:30 pmRNSTotal Voting Rights
29th Jul 20257:00 amRNSTransaction in Own Shares
28th Jul 20257:00 amRNSTransaction in Own Shares
25th Jul 20257:00 amRNSTransaction in Own Shares
24th Jul 20257:00 amRNSTransaction in Own Shares
23rd Jul 20254:15 pmRNSTotal Voting Rights
23rd Jul 20257:00 amRNSTransaction in Own Shares
22nd Jul 20257:00 amRNSTransaction in Own Shares
21st Jul 20257:00 amRNSTransaction in Own Shares
18th Jul 20257:00 amRNSTransaction in Own Shares
17th Jul 20257:00 amRNSTransaction in Own Shares
16th Jul 20257:00 amRNSTransaction in Own Shares
15th Jul 20254:45 pmRNSTotal Voting Rights
15th Jul 20257:00 amRNSTransaction in Own Shares
14th Jul 20257:00 amRNSTransaction in Own Shares
11th Jul 20257:00 amRNSTransaction in Own Shares
10th Jul 20257:00 amRNSTransaction in Own Shares
9th Jul 20257:00 amRNSTransaction in Own Shares
8th Jul 20252:30 pmRNSTotal Voting Rights
8th Jul 20257:00 amRNSTransaction in Own Shares
7th Jul 20257:00 amRNSTransaction in Own Shares
4th Jul 20257:00 amRNSTransaction in Own Shares
3rd Jul 20257:00 amRNSTransaction in Own Shares
2nd Jul 20257:00 amRNSTransaction in Own Shares
1st Jul 20254:00 pmRNSTotal Voting Rights
1st Jul 20257:00 amRNSTransaction in Own Shares
30th Jun 20253:30 pmRNSTotal Voting Rights
30th Jun 202510:00 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.